Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SAB Biotherapeutics, Inc. - Common Stock
(NQ:
SABS
)
4.150
-0.440 (-9.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about SAB Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 19, 2025
Via
Benzinga
Why Is SAB BIO Stock Trading Lower On Tuesday?
↗
January 28, 2025
SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 19, 2025
Via
Benzinga
Top movers in Friday's session
↗
September 19, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Which stocks are gapping on Friday?
↗
September 19, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Which stocks are moving before the opening bell on Wednesday?
↗
September 03, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 21, 2025
Via
Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
↗
January 28, 2025
Via
Benzinga
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
↗
January 28, 2025
Via
Benzinga
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
↗
January 28, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 18, 2024
Via
Benzinga
SABS Stock Earnings: SAB Biotherapeutics Beats EPS for Q2 2024
↗
August 09, 2024
SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 23, 2024
Via
Benzinga
SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024
↗
May 21, 2024
SABS stock results show that SAB Biotherapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday
↗
January 03, 2024
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
↗
December 01, 2023
The Dow Jones closed higher by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia
↗
November 29, 2023
SAB Biotherapeutics Inc (NASDAQ: SABS) announced that the first HUMAN trial participants (Fully HUman anti-thymocyte biologic in a first-in-MAN clinical study) have been dosed in Australia.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 24, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
